These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22819820)

  • 1. Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3.
    Zeng B; Li Z; Chen R; Guo N; Zhou J; Zhou Q; Lin Q; Cheng D; Liao Q; Zheng L; Gong Y
    FEBS Lett; 2012 Sep; 586(19):3271-8. PubMed ID: 22819820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells.
    Guo N; Chen R; Li Z; Liu Y; Cheng D; Zhou Q; Zhou J; Lin Q
    Acta Biochim Biophys Sin (Shanghai); 2011 May; 43(5):354-61. PubMed ID: 21450690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line.
    Iwaki J; Kikuchi K; Mizuguchi Y; Kawahigashi Y; Yoshida H; Uchida E; Takizawa T
    PLoS One; 2013; 8(7):e69496. PubMed ID: 23922722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells.
    Qiu YH; Wei YP; Shen NJ; Wang ZC; Kan T; Yu WL; Yi B; Zhang YJ
    Cell Physiol Biochem; 2013; 32(5):1331-41. PubMed ID: 24280681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
    Xiong X; Sun D; Chai H; Shan W; Yu Y; Pu L; Cheng F
    Biochem Biophys Res Commun; 2015 Sep; 465(2):262-9. PubMed ID: 26255969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
    Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist.
    Li B; Han Q; Zhu Y; Yu Y; Wang J; Jiang X
    FEBS J; 2012 Jul; 279(13):2393-8. PubMed ID: 22540680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-101 inhibits the migration and invasion of intrahepatic cholangiocarcinoma cells via direct suppression of vascular endothelial growth factor-C.
    Deng G; Teng Y; Huang F; Nie W; Zhu L; Huang W; Xu H
    Mol Med Rep; 2015 Nov; 12(5):7079-85. PubMed ID: 26299768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
    Wu J; Yang B; Zhang Y; Feng X; He B; Xie H; Zhou L; Wu J; Zheng S
    Int J Biol Sci; 2019; 15(8):1591-1599. PubMed ID: 31360102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOV/CCN3 Promotes Cell Migration and Invasion in Intrahepatic Cholangiocarcinoma via miR-92a-3p.
    Liang T; Shen L; Ji Y; Jia L; Dou Y; Guo L
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver.
    Liu W; Chen JR; Hsu CH; Li YH; Chen YM; Lin CY; Huang SJ; Chang ZK; Chen YC; Lin CH; Gong HY; Lin CC; Kawakami K; Wu JL
    Hepatology; 2012 Dec; 56(6):2268-76. PubMed ID: 22729936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc.
    Wu YF; Li ZR; Cheng ZQ; Yin XM; Wu JS
    Biomed Pharmacother; 2017 Dec; 96():7-13. PubMed ID: 28961507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
    Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY
    Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
    Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J
    Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.
    Li J; Tian F; Li D; Chen J; Jiang P; Zheng S; Li X; Wang S
    FEBS Lett; 2014 Sep; 588(18):3491-500. PubMed ID: 25131931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.
    Yang H; Li TW; Peng J; Tang X; Ko KS; Xia M; Aller MA
    Gastroenterology; 2011 Jul; 141(1):378-88, 388.e1-4. PubMed ID: 21440549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.
    Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q
    Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.